Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
33.74
-1.66 (-4.69%)
At close: Apr 28, 2026, 4:00 PM EDT
33.09
-0.65 (-1.93%)
After-hours: Apr 28, 2026, 5:37 PM EDT
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.61 billion as of April 28, 2026. Its market cap has increased by 412.05% in one year.
Market Cap
1.61B
Enterprise Value
1.13B
1-Year Change
412.05%
Ranking
Category
Stock Price
$33.74
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.61B, an increase of 168.17%. That is a compound annual growth rate of 68.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.69B | 17.02% |
| Dec 31, 2025 | 1.45B | 122.86% |
| Dec 31, 2024 | 648.87M | 7.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taysha Gene Therapies | 1.84B |
| Vericel | 1.82B |
| Harmony Biosciences Holdings | 1.78B |
| Palvella Therapeutics | 1.77B |
| Innoviva | 1.75B |
| Nurix Therapeutics | 1.72B |
| Sionna Therapeutics | 1.71B |
| Nuvation Bio | 1.70B |